mhurhangee/patent-ind-claim-en huggingface dataset:
A tire component, the tire component comprising a rubber composition that is based upon a cross-linkable elastomer composition, the cross-linkable rubber composition comprising, per 100 parts by weight of rubber (phr): a highly unsaturated diene elastomer; a reinforcing filler; between 3 phr and 10 phr of TMQ, wherein the TMQ is poly-2,2,4-trimethyl- 1,2-dihydroquinoline; between 10 phr and 30 phr of a methylene acceptor that is a novolac resin; and a methylene donor. a highly unsaturated diene elastomer; a reinforcing filler; between 3 phr and 10 phr of TMQ, wherein the TMQ is poly-2,2,4-trimethyl- 1,2-dihydroquinoline; between 10 phr and 30 phr of a methylene acceptor that is a novolac resin; and a methylene donor.
A compound 5-(2-((5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)amino)-5-fluoropyrimidin-4-yl)-N,4-dimethylthiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof.
Use of Mycobacterium avium non-serovar specific GPL (nonserovar Glycopeptidolipid, nsGPL) antigen of Formula (I) wherein R 1 is wherein R 3 is an alkyl or alkenyl chain having from 1 to 34 carbon atoms; wherein R 4 is -OH or -OCH 3; and wherein R 5 is -OH or -OCH 3; for the in vitro diagnosis or detection of infections caused not only by Mycobacterium avium but caused by any non-tuberculous mycobacteria selected from the group consisting of: Mycobacterium abcessus, Mycobacterium chimaera, Mycobacterium intracellulare, Mycobacterium malmoense and Mycobacterium xenopi. wherein R 1 is wherein R 3 is an alkyl or alkenyl chain having from 1 to 34 carbon atoms; wherein R 4 is -OH or -OCH 3; and wherein R 5 is -OH or -OCH 3; for the in vitro diagnosis or detection of infections caused not only by Mycobacterium avium but caused by any non-tuberculous mycobacteria selected from the group consisting of: Mycobacterium abcessus, Mycobacterium chimaera, Mycobacterium intracellulare, Mycobacterium malmoense and Mycobacterium xenopi.
A process for the production of 1,1,2,3-tetrachloropropene from one or more chlorinated alkanes comprising 1,2-dichloropropane, comprising at least one liquid phase chlorination step conducted in the presence of a free radical initiator and at least one dehydrochlorination step wherein the free radical initiator comprises an azo compound, UV light, or a combination thereof and wherein in the chlorination step the conversion of 1,2-dichloropropane to pentachlorinated propanes is maintained at less than or equal to 30%.
A medicament which comprises thrombomodulin as an active ingredient for use in therapeutic treatment and/or improvement of sepsis, wherein said medicament is to be administered to a patient with severe sepsis accompanied with one or more organ dysfunctions, wherein a value of International Normalized Ratio (INR) of a plasma specimen obtained from said patient is more than 1.4.
A modular workstation transport apparatus operable as one modular workstation transport apparatus in a series of modular workstation transport apparatus, the modular workstation transport apparatus comprising: a first axial transport mechanism for transporting a workpiece along a first axial direction ; a second axial transport mechanism for transporting the workpiece along a second axial direction , wherein the second axial direction is opposite the first axial direction; a working area configured for performing a manufacturing process on the workpiece; a first working area transport mechanism operable to transport the workpiece from the first axial transport mechanism to the working area a second working area transport mechanism configured to transport the workpiece from the working area to the second axial transport mechanism ; the apparatus being configured to provide first and second exits allowing transport of the workpiece from the working area, the first exit back to the first axial transport mechanism and the second exit to the second axial transport mechanism and: the first working area transport mechanism is further operable to transport the workpiece back from the working area to the first axial transport mechanism . a first axial transport mechanism for transporting a workpiece along a first axial direction ; a second axial transport mechanism for transporting the workpiece along a second axial direction , wherein the second axial direction is opposite the first axial direction; a working area configured for performing a manufacturing process on the workpiece; a first working area transport mechanism operable to transport the workpiece from the first axial transport mechanism to the working area a second working area transport mechanism configured to transport the workpiece from the working area to the second axial transport mechanism ; the apparatus being configured to provide first and second exits allowing transport of the workpiece from the working area, the first exit back to the first axial transport mechanism and the second exit to the second axial transport mechanism and: the first working area transport mechanism is further operable to transport the workpiece back from the working area to the first axial transport mechanism .
An ultrasonic flowmeter device configured to determine the flow velocity of a fluid flowing in a line , comprising a plurality of ultrasonic transducers (16a-e) having a plurality of measuring paths (18a-d) at each of which two of the ultrasonic transducers (16a-e) are arranged opposite to one another with the flow therebetween at a mutual axial distance (Δx) in the longitudinal direction of the line , and comprising an evaluation unit which is configured to calculate the flow velocity from time of flight differences of ultrasonic signals along the respective measuring paths (18a-d) in the direction with the flow and against the flow, the measuring paths (18a-d) having a different axial offset (Δx), characterized in that the evaluation unit is configured to estimate, from the plurality of measurements on the plurality of measuring paths (18a-d), at least one characteristic value of a function which describes the oscillatory dependence of the time of flight difference on the axial distance (Δx) of the ultrasonic transducer (16a-e) by linear adaption or reconstruction of the oscillation, and to calculate the flow velocity from the characteristic value.
Pistol comprising an unlocking mechanism for a pistol magazine, comprising at least two control buttons arranged to the right and left of a handle into which a magazine can be inserted, each control button being fastened to one end of a control lever controlling the translation of a lock cam arranged at the front or the back of the handle , said lock cam comprising a lock, cooperating in use with a stop surface arranged on the front or back surface of the magazine so as to lock or unlock said magazine , at least one spring holding the lock cam in the magazine lock position in the absence of pressure applied on the control button , and each control lever comprising a control lever lug bearing on a corresponding lock cam lug of the lock cam , the lock cam being configured to be translated when one of the control buttons is actuated and the unlocking device comprising two control lever springs holding the control levers in locked position, so as to make the movement of the left and right control buttons independent of one another.
Energy storage apparatus for providing electrical energy, having a measuring device for capturing an electrical load profile to be provided and operating state values of electrochemical energy storage devices ; a data storage device for storing data relating to at least one assessment profile (BP) for a respective electrochemical energy storage device , which assessment profile represents effects of operating parameters on a respective criterion of a respective electrochemical energy storage device; a computer device for dividing the electrical load profile to be provided into partial load profiles and for assigning them to a respective best electrochemical energy storage device with regard to the respective criterion taking into account its operating state values; an open-loop control device for controlling the electrochemical energy storage devices selected by means of the assignment to jointly provide electrical power for the electrical load profile, characterized in that the criteria are energy density and/or power density, and in that the respective ratios of a current power to the maximum power of a respective electrochemical energy storage device to the ratio of the current power to the maximum power of the energy storage apparatus are different.
Lidocaine for use in the treatment of systemic and distant hyperinflammatory syndrome in a mammalian patient, by primary lymph node targeted administration of lidocaine in the said patient to a concentration in the said targeted lymph nodes that is above the maximal tolerable plasma level of lidocaine in the said mammal, wherein the lidocaine is delivered directly from the administration site to the lymph node, - the administration route being chosen from: - transmucosal and transdermal administration, the lidocaine being administered in lipophilic form, and/or - invasive administration chosen from intradermal and subcutaneous, including subdermal, administration, the lidocaine being in hydrophilic form, - and wherein the administration is chosen from: - a bolus dosage comprising at least 4.7 mg lidocaine, administered 2 - 10 times daily and - continuous infusion of the lidocaine, the dosage comprising at least 1 mg lidocaine per kg body weight per hour, - and wherein the lidocaine is administered in a liquid medium comprising at least 1 w/v% lidocaine. - the administration route being chosen from: - transmucosal and transdermal administration, the lidocaine being administered in lipophilic form, and/or - invasive administration chosen from intradermal and subcutaneous, including subdermal, administration, the lidocaine being in hydrophilic form, - transmucosal and transdermal administration, the lidocaine being administered in lipophilic form, and/or - invasive administration chosen from intradermal and subcutaneous, including subdermal, administration, the lidocaine being in hydrophilic form, - and wherein the administration is chosen from: - a bolus dosage comprising at least 4.7 mg lidocaine, administered 2 - 10 times daily and - continuous infusion of the lidocaine, the dosage comprising at least 1 mg lidocaine per kg body weight per hour, - a bolus dosage comprising at least 4.7 mg lidocaine, administered 2 - 10 times daily and - continuous infusion of the lidocaine, the dosage comprising at least 1 mg lidocaine per kg body weight per hour, - and wherein the lidocaine is administered in a liquid medium comprising at least 1 w/v% lidocaine.
A nutritional composition comprising 2-fucosyl-lactose for use in enhancing learning in an individual subjected to psychological stress early in life whereby the hippocampal long-term potentiation response is enhanced in the individual.
A method of controlling a power generation system , the method comprising: identifying a trigger indicative of a future change in electrical power output by the power generation system to a first power level; controlling the power generation system to increase the electrical power output to a second power level in response to the trigger, the increase to the second power level providing a faster transient thrust response by increasing the electrical power output by the power generation system before the future change is needed by a propulsion system , the second power level being equal to, or less than the first power level; and controlling supply of at least a portion of the electrical power output from the power generation system at the second power level to an electrical energy storage system to charge the electrical energy storage system . identifying a trigger indicative of a future change in electrical power output by the power generation system to a first power level; controlling the power generation system to increase the electrical power output to a second power level in response to the trigger, the increase to the second power level providing a faster transient thrust response by increasing the electrical power output by the power generation system before the future change is needed by a propulsion system , the second power level being equal to, or less than the first power level; and controlling supply of at least a portion of the electrical power output from the power generation system at the second power level to an electrical energy storage system to charge the electrical energy storage system .
A Surface Enhanced Spectroscopy-Active Composite Nanoparticle (SACN) comprising: a) an anisotropic metal nanoparticle; b) a SERS-active reporter molecule associated with said anisotropic metal nanoparticle; c) SiO 2 encapsulating the anisotropic metal nanoparticle; wherein the SERS-active reporter molecule sits at the interface between the metal nanoparticle and the encapsulant; optionally wherein the SiO 2 encapsulant further comprises a reactive group selected from the group consisting of an -SH group, a -NH 2 group, and a -COO- group. a) an anisotropic metal nanoparticle; b) a SERS-active reporter molecule associated with said anisotropic metal nanoparticle; c) SiO 2 encapsulating the anisotropic metal nanoparticle;
A method by a terminal in a wireless communication system, the method comprising: receiving , from a base station, configuration information of interference measurement resource, IMR, for measuring interferences caused by plural transmission points, TPs; receiving, from the base station, control information related to the terminal including scheduling information on a physical downlink shared channel, PDSCH; determining whether IMR-based interference measurement and PDSCH reception occur at a same subframe based on the configuration information of the IMR and the scheduling information; and transmitting, to the base station, channel state information generated according to a result of the determination. receiving , from a base station, configuration information of interference measurement resource, IMR, for measuring interferences caused by plural transmission points, TPs; receiving, from the base station, control information related to the terminal including scheduling information on a physical downlink shared channel, PDSCH; determining whether IMR-based interference measurement and PDSCH reception occur at a same subframe based on the configuration information of the IMR and the scheduling information; and transmitting, to the base station, channel state information generated according to a result of the determination.
A multimeric polypeptide comprising: a heterodimeric polypeptide comprising: a) a first polypeptide comprising, in order from N-terminus to C-terminus: i) a peptide epitope; and ii) a first major histocompatibility complex (MHC) polypeptide; b) a second polypeptide comprising a second MHC polypeptide, and c) at least one immunomodulatory polypeptide, wherein the first and/or the second polypeptide comprises the at least one immunomodulatory polypeptide, wherein the first MHC polypeptide is a β-microglobulin polypeptide and wherein the second MHC polypeptide is an MHC class I heavy chain polypeptide, wherein the peptide epitope is a pathogen-associated epitope, and optionally, wherein the multimeric polypeptide comprises an immunoglobulin (Ig) Fc polypeptide or a non-Ig scaffold. a heterodimeric polypeptide comprising: a) a first polypeptide comprising, in order from N-terminus to C-terminus: i) a peptide epitope; and ii) a first major histocompatibility complex (MHC) polypeptide; b) a second polypeptide comprising a second MHC polypeptide, and c) at least one immunomodulatory polypeptide, a) a first polypeptide comprising, in order from N-terminus to C-terminus: i) a peptide epitope; and ii) a first major histocompatibility complex (MHC) polypeptide; i) a peptide epitope; and ii) a first major histocompatibility complex (MHC) polypeptide; b) a second polypeptide comprising a second MHC polypeptide, and c) at least one immunomodulatory polypeptide, wherein the first and/or the second polypeptide comprises the at least one immunomodulatory polypeptide, wherein the first MHC polypeptide is a β-microglobulin polypeptide and wherein the second MHC polypeptide is an MHC class I heavy chain polypeptide, wherein the peptide epitope is a pathogen-associated epitope, and optionally, wherein the multimeric polypeptide comprises an immunoglobulin (Ig) Fc polypeptide or a non-Ig scaffold.
A method of configuring a specific field device, the method comprising the steps of: - identifiying an original Open Platform Communications Unified Architecture "OPC UA" server provided for a field device of the same type as the specific field device; - creating a data set of values of parameters of the original OPC UA server; - storing the created data set of the values of parameters of the original OPC UA server in a storage medium separate to the original OPC UA server; and - generating a configuration for the specific field device comprising utilizing the created data set of the values of parameters of the original OPC UA server in the storage medium separate to the original OPC UA server. - identifiying an original Open Platform Communications Unified Architecture "OPC UA" server provided for a field device of the same type as the specific field device; - creating a data set of values of parameters of the original OPC UA server; - storing the created data set of the values of parameters of the original OPC UA server in a storage medium separate to the original OPC UA server; and - generating a configuration for the specific field device comprising utilizing the created data set of the values of parameters of the original OPC UA server in the storage medium separate to the original OPC UA server.
A Ziegler-Natta catalyst component precursor comprising a dry mechanical mixture of (a) distinct particles of adducts of formula MgCl 2 (R 1 OH) n where R 1 is a C 1 -C 8 alkyl group, and n is from 0.2 to 6 having average particle size (P50a) ranging from 5 to 100 μm as determined according to the description and (b) from 0.2 to 5.0% by weight, based on the total amount of (a)+(b), of distinct particles of a solid compound containing more than 50% by weight of SiO 2 units and having average particle size (P50b) such that the ratio P50b/P50a ranges from 0.4 to 1.5.
Electrostatic smoking installation comprising: - a chamber (11, 11', 11", 11′′′) with a first opening and a second opening for the throughflow in the chamber of a treatment medium along a flow path, - in the chamber (11, 11', 11", 11′′′) on the flow path a treatment space that is provided for receiving material to be treated , - a smoke generator for enriching the treatment medium with smoke, - a guide system for conveying the treatment medium into the chamber (11, 11', 11", 11′′′) and out of the chamber (11, 11', 11", 11′′′), - a first electrode , in particular a first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′) containing the first electrode , for ionizing the treatment medium, characterized in that - the guide system is equipped with a circulation channel that connects the first opening to the second opening , - the circulation channel is designed in such a manner that the material to be treated can be guided thereby after passing through the treatment space for at least one further passing through the treatment space again into the treatment space and - the circulation channel is designed with respect to the first electrode , in particular with respect to the first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′), that the treatment medium after passing through the treatment space can be guided via the first electrode or the first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′) before the treatment medium enters again the treatment space. - a chamber (11, 11', 11", 11′′′) with a first opening and a second opening for the throughflow in the chamber of a treatment medium along a flow path, - in the chamber (11, 11', 11", 11′′′) on the flow path a treatment space that is provided for receiving material to be treated , - a smoke generator for enriching the treatment medium with smoke, - a guide system for conveying the treatment medium into the chamber (11, 11', 11", 11′′′) and out of the chamber (11, 11', 11", 11′′′), - a first electrode , in particular a first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′) containing the first electrode , for ionizing the treatment medium, - the guide system is equipped with a circulation channel that connects the first opening to the second opening , - the circulation channel is designed in such a manner that the material to be treated can be guided thereby after passing through the treatment space for at least one further passing through the treatment space again into the treatment space and - the circulation channel is designed with respect to the first electrode , in particular with respect to the first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′), that the treatment medium after passing through the treatment space can be guided via the first electrode or the first ionization unit (22, 80, 80', 80", 80'", 80ʺʺ, 80ʺ′′′) before the treatment medium enters again the treatment space.
Device for making optical glass fibers from preforms , in particular multicomponent glass fibers, having a fiber furnace which has heating bushes , having a tracking device for holding and tracking the preforms in the heating bushes , and having a drawing and sizing installation for forwarding the glass fibers to a finishing device , characterized in the heating bushes in the fiber furnace have a matrix-like arrangement for simultaneously accommodating a plurality of preforms , the matrix main axes of the arrangement are arranged with a predetermined offset angle (α) with respect to one another, the offset angle of the matrix axes α is smaller than 90°, and the glass fibers drawn from the heating bushes are receivable by the drawing and sizing installation in the form of a band lying next to one another.